<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>There is a high frequency of serious side effects overseas in cases with a <z:hpo ids='HP_0000120'>reduced creatinine clearance</z:hpo>, for whom a 75% reduction in dose administration is recommended </plain></SENT>
<SENT sid="1" pm="."><plain>The insidence of hematological toxicity was investigated in 89 cases[L group: Ccr&lt;5 0mL/min(6 cases), M group: 50mL/min≤Ccr&lt;80mL/min(34 cases), and H group: 80mL/min≤Ccr(49 cases)]who took <z:chebi fb="0" ids="31348">capecitabine</z:chebi> alone </plain></SENT>
<SENT sid="2" pm="."><plain>The frequency of side effects was significantly high in group L[L: 6 cases(100%), M: 30 cases(88 </plain></SENT>
<SENT sid="3" pm="."><plain>2%), and H: 30 cases(61 </plain></SENT>
<SENT sid="4" pm="."><plain>2%)] </plain></SENT>
<SENT sid="5" pm="."><plain>The frequency of grade 2 or more was higher in cases with a <z:hpo ids='HP_0000082'>reduced renal function</z:hpo>[L: 5 cases(83 </plain></SENT>
<SENT sid="6" pm="."><plain>3%),M: 17 cases(50 </plain></SENT>
<SENT sid="7" pm="."><plain>0%), and H: 18 cases(36 </plain></SENT>
<SENT sid="8" pm="."><plain>7%)] </plain></SENT>
<SENT sid="9" pm="."><plain>A significantly high decrease in <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> was seen in group L[<z:hpo ids='HP_0000001'>all</z:hpo> grades; L: 5 cases(83 </plain></SENT>
<SENT sid="10" pm="."><plain>3%),M: 20 cases(58 </plain></SENT>
<SENT sid="11" pm="."><plain>8%), and H: 12 cases(24 </plain></SENT>
<SENT sid="12" pm="."><plain>5%), and a grade 2 or more; L: 5 cases (83 </plain></SENT>
<SENT sid="13" pm="."><plain>3%), M: 7 cases(20 </plain></SENT>
<SENT sid="14" pm="."><plain>6%), and H: 5 cases (10 </plain></SENT>
<SENT sid="15" pm="."><plain>2%)] </plain></SENT>
<SENT sid="16" pm="."><plain>Moreover, there was little improvement when a decrease in <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> occurred in grade 3 cases </plain></SENT>
<SENT sid="17" pm="."><plain>Our findings suggest that it is necessary to manage drug dosage for Japanese patients while considering their renal function, and to actively monitor for any side effects </plain></SENT>
</text></document>